Oriola Oyj (FRA:O5O)
Germany flag Germany · Delayed Price · Currency is EUR
1.096
-0.006 (-0.54%)
At close: Dec 4, 2025

Oriola Oyj Company Description

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally.

The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products.

In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services.

Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies.

Oriola Oyj was founded in 1907 and is headquartered in Espoo, Finland.

Oriola Oyj
Country Finland
Founded 1907
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 934
CEO Katarina Gabrielson

Contact Details

Address:
Orionintie 5
Espoo, 02200
Finland
Phone 358 1042 999
Website oriola.com

Stock Details

Ticker Symbol O5O
Exchange Frankfurt Stock Exchange
Share Class Class B Shares
Fiscal Year January - December
Reporting Currency EUR
SIC Code 5122

Key Executives

Name Position
Katarina Gabrielson Chief Executive Officer
Mats Danielsson Chief Financial Officer
Tua Stenius-Örnhjelm Head of Investor Relations